Phaseline

Companies › Ocugen

Ocugen: clinical trials, targets and expected readouts

4 active drug programs in 6 registered trials: 3 Phase 1, 2 Phase 3, 1 Phase 2; Ophthalmology; next expected readout Feb 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
OCU400
Gene therapy vector for retinitis pigmentosa and Leber congenital amaurosis
RHO, NR2E3, CEP290Phase 3Retinitis PigmentosaFeb 2027
OCU410
Gene therapy for geographic atrophy
–Phase 3Dry Age-related Macular Degeneration; Geographic AtrophyJul 2028
OCU410ST
Gene therapy for retinal degeneration
–Phase 2Stargardt Disease–
OCU200–Phase 1Center Involved Diabetic Macular Edema–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05802329OCU200Phase 1Center Involved Diabetic Macular EdemaOphthalmologyJul 2026
NCT05956626OCU410STPhase 2Stargardt DiseaseOphthalmologySep 2026
NCT06388200OCU400Phase 3Retinitis PigmentosaOphthalmologyFeb 2027
NCT05203939OCU400Phase 1Retinitis PigmentosaOphthalmologyMar 2027
NCT07770828OCU410Phase 3Dry Age-related Macular DegenerationOphthalmologyJul 2028
NCT06018558OCU410Phase 1Geographic AtrophyOphthalmologyFeb 2030

From the company's SEC filings

Cash and short-term investments of $84m on 2026-09-30; operating cash outflow about $67m a year; runway about 15 months at that burn, to Jan 2028; 1 of 2 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Agreements filed with the SEC (item 1.01), last two years

Targets

RHO (1) NR2E3 (1) CEP290 (1)

Companies with the same targets

ProQR Therapeutics Laboratoires Thea

Companies built like this

ProQR Therapeutics Laboratoires Thea Opus Genetics Kiora Pharmaceuticals Huons

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.